Combined incidence of OHSS in phase 3 trials of corifollitropin alfa for controlled ovarian stimulation

被引：0
|
作者：
Tarlatzis, B. [1 ]
Witjes, H. [2 ]
Mannaerts, B. [3 ]
机构：
[1] Papageorgiou Hosp, Human Reprod Unit, Dept Obstet & Gynecol 1, Thessaloniki, Greece
[2] Schering Plough Res Inst, Global Late Stage Stat, Oss, Netherlands
[3] Schering Plough Res Inst, Global Clin Res Womens Hlth, Oss, Netherlands
来源：
HUMAN REPRODUCTION | 2010年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：I242 / I242
页数：1
相关论文
共 50 条
  • [1] INCIDENCE OF CONGENITAL MALFORMATIONS AFTER OVARIAN STIMULATION WITH CORIFOLLITROPIN ALFA OR RECOMBINANT FSH: DATA FROM 3 RANDOMIZED CONTROLLED TRIALS
    Stegmann, B.
    Bonduelle, M.
    Gordon, K.
    Witjes, H.
    Verweij, P.
    FERTILITY AND STERILITY, 2013, 100 (03) : S59 - S59
  • [2] Ovarian stimulation with corifollitropin alfa
    Griesinger, G.
    Diedrich, K.
    Schultze-Mosgau, A.
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2011, 9 (04): : 223 - 228
  • [3] Dose Selection of Corifollitropin Alfa by Modeling and Simulation in Controlled Ovarian Stimulation
    de Greef, R.
    Zandvliet, A. S.
    de Haan, A. F. J.
    IJzerman-Boon, P. C.
    Marintcheva-Petrova, M.
    Mannaerts, B. M. J. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (01) : 79 - 87
  • [4] Corifollitropin alfa compared to daily FSH in controlled ovarian stimulation for oocyte donors
    Benchabane, M.
    Santulli, P.
    Maignien, C.
    Bourdon, M.
    De Ziegler, D.
    Chapron, C.
    Gayet, V.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2017, 45 (02): : 83 - 88
  • [5] Corifollitropin alfa for ovarian stimulation in in vitro fertilization: a systematic review and meta-analysis of randomized controlled trials
    Cozzolino, Mauro
    Vitagliano, Amerigo
    Cecchino, Gustavo Nardini
    Ambrosini, Guido
    Garcia-Velasco, Juan Antonio
    FERTILITY AND STERILITY, 2019, 111 (04) : 722 - 733
  • [6] Corifollitropin Alfa A Review of its Use in Controlled Ovarian Stimulation for Assisted Reproduction
    Croxtall, Jamie D.
    McKeage, Kate
    BIODRUGS, 2011, 25 (04) : 243 - 254
  • [7] Corifollitropin Alfa for Controlled Ovarian Stimulation in Assisted Reproductive Technologies: State of the Art
    de Carvalho, Bruno Ramalho
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2023, 45 (01): : 43 - 48
  • [8] The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist
    Seyhan, Ayse
    Ata, Baris
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2011, 3 : 243 - 255
  • [9] Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH
    Tarlatzis, Basil C.
    Griesinger, Georg
    Leader, Arthur
    Rombauts, Luk
    IJzerman-Boon, Pieta C.
    Mannaerts, Bernadette M. J. L.
    REPRODUCTIVE BIOMEDICINE ONLINE, 2012, 24 (04) : 410 - 419
  • [10] Impact of patient characteristics on the pharmacokinetics of corifollitropin alfa during controlled ovarian stimulation
    Zandvliet, Anthe S.
    Prohn, Marita
    de Greef, Rik
    van Aarle, Frank
    Sisk, Christine McCrary
    Stegmann, Barbara J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (01) : 74 - 82
12345